课题基金 / 基金详情

Research on pathophysiology and the establishment of serum biomarkers for cigarette-smoke-associated acute eosinophilic pneumonia

Research on pathophysiology and the establishment of serum biomarkers for cigarette-smoke-associated acute eosinophilic pneumonia
吸烟相关急性嗜酸细胞性肺炎的病理生理学研究及血清生物标志物的建立
批准号:
17590798
负责人:
MIYAZAKI Eishi
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MIYAZAKI Eishi的其他基金

相似基金

相关文献

中文摘要
翻译
急性嗜酸性粒细胞性肺炎(AEP)的表现与急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)非常相似,包括其特发性形式急性间质性肺炎(AIP)。急性期AEP通常缺乏外周嗜酸性粒细胞;因此,建立AEP的血清生物标志物具有临床意义。我们测量了急性肺实质疾病患者血清中胸腺和激活调节趋化因子(TARC/CCL17)、eotaxin/CCL11、KL-6和表面活性蛋白- d (SP-D)的水平,包括AEP (n=17)、AIP (n=13)、肺炎相关ALI/ARDS (n=12)和肺泡出血(n=7)。通过测量受试者工作特征曲线下面积(AUC)来评估各标志物的诊断能力。AEP患者血清TARC/CCL17水平明显高于其他疾病组。更重要的是,即使在急性期外周嗜酸性粒细胞缺失的情况下,AEP患者也观察到高循环TARC/CCL17水平。TARC/CCL17的AUC最大,截断点在6259 ~ 7039 pg/ml之间的TARC/CCL17水平区分AEP与其他综合征的敏感性和特异性为100%。大多数AEP患者KL-6水平较低,截止值敏感性为81.6%,特异性为100%。eotaxin/CCL11和SP-D的AUC较小,分别为0.73(95%可信区间[CI], 0.60 ~ 0.85)和0.53 (95% CI, 0.31 ~ 0.64)。本研究表明,循环TARC/CCL17和KL-6的测定有助于区分AEP与其他原因的急性肺损伤。
英文摘要
The presentation of acute eosinophilic pneumonia (AEP) closely resembles that of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) including its idiopathic form, acute interstitial pneumonia (AIP). AEP usually lacks peripheral eosinophilia at the acute phase; therefore, the establishment of serum biomarkers for AEP would be clinically useful. We measured the levels of thymus-and activation-regulated chemokine (TARC/CCL17), eotaxin/CCL11, KL-6 and surfactant protein-D (SP-D) in serum for patients with acute parenchymal lung diseases including AEP (n=17), AIP (n=13), pneumonia-associated ALI/ARDS (n=12), and alveolar hemorrhage (n=7). To evaluate the diagnostic ability of each marker was estimated by measuring the area under the receiver operating characteristic curve (AUC). The serum TARC/CCL17 levels of AEP patients were much higher than those of patients in other disease groups. More importantly, high circulating TARC/CCL17 levels were observed in AEP even at acute phase when peripheral eosinophilia was absent. TARC/CCL17 showed the largest AUC, and the TARC/CCL17 levels with cut-off points between 6,259 and 7,039pg/ml discriminated AEP from other syndromes with sensitivity and specificity of 100%. The KL-6 level was low in most patients with AEP, and the sensitivity was 81.6% in cutoff with 100% specificity. The AUC for eotaxin/CCL11 and SP-D was small with the values of 0.73 (95% confidence interval [CI], 0.60 to 0.85) and 0.53 (95% CI, 0.31 to 0.64), respectively. This study indicates that the measurement of circulating TARC/CCL17 and KL-6 is useful for discriminating AEP from other causes of acute lung injury.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1177/117727190600100012
发表时间: 2006-01
期刊: Biomarker Insights
影响因子: 3.8
作者: [O. Matsuno;E. Miyazaki;S. Nureki;T. Ueno;M. Ando;T. Kumamoto]
通讯作者: O. Matsuno;E. Miyazaki;S. Nureki;T. Ueno;M. Ando;T. Kumamoto
DOI: 10.1620/tjem.212.49
发表时间: 2007-05-01
期刊: TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
影响因子: 2.2
作者: [Matsuno, Osamu, Okubo, Toshiyuki, Kumamoto, Toshihide]
通讯作者: Kumamoto, Toshihide
DOI: 10.1016/j.clim.2005.03.001
发表时间: 2005-07-01
期刊: CLINICAL IMMUNOLOGY
影响因子: 8.6
作者: [Nureki, S, Miyazaki, E, Tsuda, T]
通讯作者: Tsuda, T
Acute eosinophilic pneumonia caused by Candida albicans
白色念珠菌引起的急性嗜酸细胞性肺炎
DOI: --
发表时间: 2007
期刊: Respiratory Medicine 20 (Epub ahead of print)
影响因子: --
作者: [Matsuno O, Ueno T, Takenaka R, Okubo T, Tokunaga Y, Nureki S, Ando M, Miyazaki E, Kumamoto T]
通讯作者: Kumamoto T
共 14 条
    Osteopontin in the pathogenesis of acute eosinophilic pneumonia
    • 批准号:
      22590866
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      MIYAZAKI Eishi
    • 依托单位:
    Research on pathogenesis of cigarette-smoke-associated acute eosinophilic pneumonia
    Gene Regulation by Staphylococcus Aureas rsbU and rsbV
    • 批准号:
      13670277
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.83万
    • 财政年份:
      2001
    • 负责人:
      MIYAZAKI Eishi
    • 依托单位:
    海外基金